Lefitolimod (TLR agonist) and ipilimumab in patients with advanced solid tumors: A phase I trial

被引：0
|
作者：
Nardo, Mirella
Reilley, Matthew
Biter, Amadeo
Lim, Joann
Bean, Stacie A.
Nguyen, Ly Minh
Bhosale, Priya
Ager, Casey
Couillault, Coline A.
Piha-Paul, Sarina A.
Fu, Siqing
Tsimberidou, Apostolia Maria
Yap, Timothy A.
Naing, Aung
Ahnert, Jordi Rodon
Subbiah, Vivek
Karp, Daniel D.
Curran, Michael A.
Hong, David S.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Virginia, Charlottesville, VA USA
[3] Columbia Univ, Med Ctr, New York, NY USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2564
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I trial of combination becatecarin and oxaliplatin in patients with advanced solid tumors
    Manda, S.
    Mauser, C.
    Bokar, J.
    Cooney, M.
    Brell, J.
    Krishnamurthi, S.
    Savvides, P.
    Ivy, P.
    Remick, S.
    Dowlati, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors
    Stephen V. Liu
    Susan G. Groshen
    Karen Kelly
    Karen L. Reckamp
    Chandra Belani
    Timothy W. Synold
    Amir Goldkorn
    Barbara J. Gitlitz
    Mihaela C. Cristea
    I-Yeh Gong
    Thomas J. Semrad
    Yucheng Xu
    Tong Xu
    Marianna Koczywas
    David R. Gandara
    Edward M. Newman
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 723 - 732
  • [33] Phase I trial of CRD3874-SI, a systemically administered STING agonist, in patients with advanced solid tumors.
    Kelly, Ciara Marie
    Avutu, Viswatej
    Banks, Lauren Baker
    Chan, Jason Earl
    Chi, Ping
    Clark, Camron
    Counihan, Olivia
    Dickson, Mark Andrew
    Gounder, Mrinal M.
    Keohan, Mary Louise
    Maki, Robert G.
    Movva, Sujana
    Reed, Damon R.
    Rosenbaum, Evan
    Szostek, Anna
    Qin, Li-Xuan
    Wong, Phillip
    Tap, William D.
    D'Angelo, Sandra P.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] Phase I trial of fruquintinib in patients with advanced solid tumors; Results of the dose escalation phase
    Wang-Gillam, A.
    Yeckes-Rodin, H.
    Kosmo, M. A.
    Stanton, T.
    Park, H.
    Songhua, F.
    Sauter, N. P.
    Kania, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 175 - +
  • [35] Sunitinib and bevacizumab in advanced solid tumors: A phase I trial
    Cooney, M. M.
    Garcia, J. A.
    Elson, P.
    Mekhail, T.
    Dreicer, R.
    Nock, C. J.
    Bokar, J. A.
    Tyler, A.
    Beatty, K.
    Bukowski, R. M.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Phase I trial of gemcitabine and paclitaxel in advanced solid tumors
    Lim, N
    Lara, PN
    Lau, DHM
    Edelman, MJ
    Tanaka, M
    Al-Jazayrly, G
    Houston, J
    Lauder, I
    Gandara, DR
    CANCER INVESTIGATION, 2003, 21 (01) : 7 - 13
  • [37] Phase I clinical trial of VTX-2337, a selective toll-like receptor 8 (TLR8) agonist, in patients with advanced solid tumors.
    Cohen, P. A.
    Northfelt, D. W.
    Weiss, G. J.
    Von Hoff, D. D.
    Manjarrez, K.
    Dietsch, G.
    Hershberg, R. M.
    Ramanathan, R. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] A phase I trial of riluzole and sorafenib in patients with advanced solid tumors and melanoma.
    Mehnert, Janice M.
    Semlani, Neha
    Wen, Yvonne
    Tan, Antoinette R.
    Moss, Rebecca Anne
    Adams, Shari
    Stein, Mark N.
    Ross, Mikel
    Kane, Michael P.
    Gibbon, Darlene
    Wright, John Joseph
    Aisner, Joseph
    Chen, Suzie
    Goydos, James S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
    Lockhart, Albert C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Mita, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [40] A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors
    Mehnert, Janice M.
    Kaveney, Amanda D.
    Malhotra, Jyoti
    Spencer, Kristen
    Portal, Daniella
    Goodin, Susan
    Tan, Antoinette R.
    Aisner, Joseph
    Moss, Rebecca A.
    Lin, Hongxia
    Bertino, Joseph R.
    Gibbon, Darlene
    Doyle, Laurence A.
    White, Eileen P.
    Stein, Mark N.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (04) : 899 - 907
12345